Neogen Chemicals

₹1450 -15.5 | 1.1%

WEBSITE BSE:542665 NSE : NEOGEN 10 May, 16:01

Market Cap ₹3825 Cr.

Stock P/E 104.3

P/B 5

Current Price ₹1450

Book Value ₹ 288.2

Face Value 10

52W High ₹1851.1

Dividend Yield 0.14%

52W Low ₹ 1148.8

Edit Ratio

Neogen Chemicals Research see more...

Overview Inc. Year: 1989Industry: Chemicals

Neogen Chemicals Ltd manufactures and sells speciality chemical substances in India. It gives organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds, unsaturated bromine derivatives, bromo hydroxy derivatives, and different compounds; inorganic bromine compounds and lithium salts; grignard reagents; and intermediates. The employer also gives custom synthesis and manufacturing offerings. It serves pharmaceutical, agrochemical, engineering, flavour and fragrance, electronic-chemical, refrigeration, construction chemical substances, pharmaceutical, and speciality polymer industries, in addition to heating, air flow, and air-conditioning industries. The business enterprise also exports its products to 28 international locations. Neogen Chemicals Ltd established in 1989 and is primarily based in Thane, India.

Neogen Chemicals Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Neogen Chemicals Quarterly Results

#(Fig in Cr.)	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Net Sales	133	157	148	148	186	204	165	162	164	200
Other Income	0	1	1	0	1	2	2	2	2	2
Total Income	133	158	149	149	188	206	167	164	166	202
Total Expenditure	109	130	123	124	156	171	137	136	144	164
Operating Profit	24	27	26	25	32	34	30	28	22	38
Interest	6	5	6	7	7	9	11	11	11	10
Depreciation	4	4	4	4	4	4	5	6	6	6
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	14	19	16	14	21	21	14	11	6	22
Provision for Tax	3	3	5	4	6	6	4	3	5	6
Profit After Tax	10	16	11	10	15	14	10	8	1	17
Adjustments	-0	0	0	0	-0	0	0	0	0	0
Profit After Adjustments	10	16	11	10	15	14	10	8	1	17
Adjusted Earnings Per Share	4.5	6.3	4.5	4	5.9	5.7	3.9	3.2	0.4	6.4

Neogen Chemicals Profit & Loss

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	74	84	100	110	161	239	306	336	487	686	691
Other Income	0	1	0	0	1	1	0	0	1	4	8
Total Income	74	85	100	110	162	240	306	337	488	691	699
Total Expenditure	62	71	86	90	132	196	248	272	401	575	581
Operating Profit	12	14	14	20	30	44	58	65	88	116	118
Interest	5	5	5	8	10	12	12	14	19	29	43
Depreciation	1	1	1	1	2	3	5	7	12	16	23
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	6	8	8	11	17	29	41	44	57	71	53
Provision for Tax	3	3	3	4	6	8	12	13	12	21	18
Profit After Tax	4	5	5	8	11	21	29	31	45	50	36
Adjustments	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	4	5	5	8	11	21	29	31	45	50	36
Adjusted Earnings Per Share	1.8	2.5	2.6	3.8	5.5	10.4	12.3	13.4	17.9	20	13.9

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	41%	31%	34%	0%
Operating Profit CAGR	32%	26%	31%	0%
PAT CAGR	11%	20%	35%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-5%	17%	41%	NA%
ROE Average	11%	15%	21%	21%
ROCE Average	13%	15%	18%	22%

Neogen Chemicals Balance Sheet

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	20	23	28	42	50	70	156	183	439	483
Minority's Interest	0	0	0	0	0	0	0	0	0	0
Borrowings	5	5	5	37	38	51	30	116	122	129
Other Non-Current Liabilities	2	3	3	7	8	9	18	15	20	32
Total Current Liabilities	37	38	46	67	84	117	150	178	218	410
Total Liabilities	63	69	80	152	180	246	355	492	799	1054
Fixed Assets	14	13	17	56	67	83	111	127	285	347
Other Non-Current Assets	3	2	2	6	7	4	13	125	22	51
Total Current Assets	46	53	61	90	107	160	231	240	492	656
Total Assets	63	69	80	152	180	246	355	492	799	1054

Neogen Chemicals Cash Flow

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	2	2	2	2	3	2	2	1	1	45
Cash Flow from Operating Activities	3	9	9	0	12	-4	-35	84	1	-30
Cash Flow from Investing Activities	-1	-2	-4	-33	-13	-20	-29	-135	-146	-94
Cash Flow from Financing Activities	-2	-6	-4	33	-0	24	63	51	188	100
Net Cash Inflow / Outflow	0	1	0	1	-1	0	-1	-0	44	-25
Closing Cash & Cash Equivalent	2	2	2	3	2	2	1	1	45	21

Neogen Chemicals Ratios

#	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	1.82	2.55	2.59	3.84	5.49	10.43	12.28	13.43	17.89	20.04
CEPS(Rs)	2.28	3.01	3.09	4.48	6.42	11.85	14.53	16.39	22.58	26.53
DPS(Rs)	2	2	0.45	0	1	1.5	2	2.25	2.75	3
Book NAV/Share(Rs)	9.81	11.76	13.77	20.98	25.21	34.96	66.96	78.44	176.12	193.47
Core EBITDA Margin(%)	14.36	13.84	12.96	16.45	17.68	16.99	16.7	16.06	17.77	16.27
EBIT Margin(%)	13.72	13.9	12.19	15.63	16.98	16.12	15.25	14.47	15.63	14.57
Pre Tax Margin(%)	7.75	8.82	7.79	9.44	10.62	11.45	11.82	11.03	11.71	10.35
PAT Margin (%)	4.56	5.56	4.76	6.29	6.7	8.2	8.24	7.82	9.16	7.28
Cash Profit Margin (%)	5.71	6.58	5.68	7.37	7.83	9.31	9.75	9.54	11.56	9.64
ROA(%)	5.79	7.72	6.94	6.57	6.6	9.81	9.53	7.4	6.91	5.39
ROE(%)	18.59	23.61	20.3	22	23.78	34.73	25.31	18.47	14.34	10.84
ROCE(%)	24.32	27.42	26.11	23.01	22.85	25.52	21.93	16.75	14.33	13.25
Receivable days	75.77	68.93	56.68	72.13	81.81	72.86	71.35	70.02	70.43	76.3
Inventory Days	96.98	90.82	93.95	107.83	100.15	87.39	106.19	111.05	115.59	129.67
Payable days	116.91	112.7	114.11	150.54	130.19	103.11	77.99	94.13	109.49	119.98
PER(x)	0	0	0	0	0	0	28.59	64.36	97.51	64.03
Price/Book(x)	0	0	0	0	0	0	5.24	11.02	9.91	6.63
Dividend Yield(%)	0	0	0	0	0	0	0.57	0.26	0.16	0.23
EV/Net Sales(x)	0.38	0.31	0.44	0.78	0.62	0.58	3.12	6.63	9.3	5.16
EV/Core EBITDA(x)	2.37	1.93	3.08	4.24	3.39	3.14	16.42	34.59	51.69	30.51
Net Sales Growth(%)	0	13.7	19.52	9.74	46.41	48.34	28.05	9.89	44.84	40.83
EBIT Growth(%)	0	16.01	4.35	43.04	46.66	47.95	28.72	9.35	31.34	31.28
PAT Growth(%)	0	39.58	1.87	47.59	43.68	90.7	36.81	9.33	42.45	11.97
EPS Growth(%)	0	39.58	1.77	48.32	42.97	89.94	17.72	9.35	33.25	11.97
Debt/Equity(x)	1.3	1.03	0.96	1.65	1.63	1.71	0.88	1.18	0.51	0.75
Current Ratio(x)	1.26	1.4	1.34	1.35	1.28	1.37	1.54	1.35	2.26	1.6
Quick Ratio(x)	0.68	0.76	0.64	0.75	0.68	0.75	0.68	0.71	1.36	0.89
Interest Cover(x)	2.3	2.73	2.77	2.53	2.67	3.45	4.45	4.21	3.99	3.45
Total Debt/Mcap(x)	0	0	0	0	0	0	0.17	0.11	0.05	0.11

Neogen Chemicals Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	64.33	60.19	60.19	60.19	60.19	60.19	60.19	60.19	56.89	56.89
FII	4.73	4.36	4.28	3.74	3.99	4.12	4.3	4.24	4.51	4.56
DII	14.09	18.64	19.33	19.12	18.88	20.01	19.88	20.25	22.84	22.14
Public	16.85	16.81	16.2	16.95	16.94	15.68	15.63	15.33	15.75	16.41
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5
FII	0.11	0.11	0.11	0.09	0.1	0.1	0.11	0.11	0.12	0.12
DII	0.33	0.46	0.48	0.48	0.47	0.5	0.5	0.5	0.6	0.58
Public	0.39	0.42	0.4	0.42	0.42	0.39	0.39	0.38	0.42	0.43
Others	0	0	0	0	0	0	0	0	0	0
Total	2.33	2.49	2.49	2.49	2.49	2.49	2.49	2.49	2.64	2.64

Pros

Company has delivered good profit growth of 35% CAGR over last 5 years

Cons

Debtor days have increased from 109.49 to 119.98days.
Stock is trading at 5 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.